166 related articles for article (PubMed ID: 31554730)
1. Outcomes of the short Synacthen test: what is the role of the 60 min sample in clinical practice?
Dineen R; Mohamed A; Gunness A; Rakovac A; Cullen E; Barnwell N; Neary C; Behan LA; Boran G; Gibney J; Sherlock M
Postgrad Med J; 2020 Feb; 96(1132):67-72. PubMed ID: 31554730
[TBL] [Abstract][Full Text] [Related]
2. Determining the utility of the 60 min cortisol measurement in the short synacthen test.
Chitale A; Musonda P; McGregor AM; Dhatariya KK
Clin Endocrinol (Oxf); 2013 Jul; 79(1):14-9. PubMed ID: 22747889
[TBL] [Abstract][Full Text] [Related]
3. Do we need 30 min cortisol measurement in the short synacthen test: a retrospective study.
Kumar R; Carr P; Moore K; Rajput Z; Ward L; Wassif WS
Postgrad Med J; 2020 Aug; 96(1138):467-472. PubMed ID: 31810992
[TBL] [Abstract][Full Text] [Related]
4. Sixty-minute post-Synacthen serum cortisol level: a reliable and cost-effective screening test for excluding adrenal insufficiency compared to the conventional short Synacthen test.
Mansoor S; Islam N; Siddiqui I; Jabbar A
Singapore Med J; 2007 Jun; 48(6):519-23. PubMed ID: 17538749
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of morning serum cortisol as an alternative to short synacthen test for the assessment of adrenal reserve; a retrospective study.
Kumar R; Carr P; Wassif W
Postgrad Med J; 2022 Feb; 98(1156):113-118. PubMed ID: 33122342
[TBL] [Abstract][Full Text] [Related]
6. How good is a morning cortisol in predicting an adequate response to intramuscular synacthen stimulation?
Yo WS; Toh LM; Brown SJ; Howe WD; Henley DE; Lim EM
Clin Endocrinol (Oxf); 2014 Jul; 81(1):19-24. PubMed ID: 24274236
[TBL] [Abstract][Full Text] [Related]
7. Role of sampling times and serum cortisol cut-off concentrations on the routine assessment of adrenal function using the standard cosyntropin test in an academic hospital from Spain: a retrospective chart review.
Ortiz-Flores AE; Santacruz E; Jiménez-Mendiguchia L; García-Cano A; Nattero-Chávez L; Escobar-Morreale HF; Luque-Ramírez M
BMJ Open; 2018 May; 8(5):e019273. PubMed ID: 29730618
[TBL] [Abstract][Full Text] [Related]
8. Validation of the 1 μg short synacthen test: an assessment of morning cortisol cut-off values and other predictors.
Perton FT; Mijnhout GS; Kollen BJ; Rondeel JM; Franken AA; Groeneveld PH
Neth J Med; 2017 Jan; 75(1):14-20. PubMed ID: 28124663
[TBL] [Abstract][Full Text] [Related]
9. "A morning cortisol is the most effective clinical predictor of short synacthen test outcome": A tertiary care centre experience.
Mathara Diddhenipothage SAD; Beck KJ; Loo H; Amiyangoda GK; Pofi R; Tomlinson JW; Pal A
Clin Endocrinol (Oxf); 2023 Aug; 99(2):142-151. PubMed ID: 37288515
[TBL] [Abstract][Full Text] [Related]
10. Tests of adrenal insufficiency.
Agwu JC; Spoudeas H; Hindmarsh PC; Pringle PJ; Brook CG
Arch Dis Child; 1999 Apr; 80(4):330-3. PubMed ID: 10086937
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic studies of nasal tetracosactide with salivary glucocorticoids for a noninvasive Short Synacthen Test.
Elder CJ; Vilela R; Johnson TN; Taylor RN; Kemp EH; Keevil BG; Cross AS; Ross RJ; Wright NP
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32593173
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of adrenal function using the human corticotrophin-releasing hormone test, low dose Synacthen test and 9am cortisol level in children and adolescents with central adrenal insufficiency.
Maguire AM; Biesheuvel CJ; Ambler GR; Moore B; McLean M; Cowell CT
Clin Endocrinol (Oxf); 2008 May; 68(5):683-91. PubMed ID: 18070143
[TBL] [Abstract][Full Text] [Related]
13. Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol.
Woods CP; Argese N; Chapman M; Boot C; Webster R; Dabhi V; Grossman AB; Toogood AA; Arlt W; Stewart PM; Crowley RK; Tomlinson JW
Eur J Endocrinol; 2015 Nov; 173(5):633-42. PubMed ID: 26294794
[TBL] [Abstract][Full Text] [Related]
14. Comparing the utility of 30- and 60-minute cortisol levels after the standard short synacthen test to determine adrenal insufficiency: A retrospective cross-sectional study.
Butt MI; Alzuhayri N; Amer L; Riazuddin M; Aljamei H; Khan MS; Abufarhaneh M; Alrajhi E; Alnassar A; Alahmed R; Aljayar DMA; Abothenain FF; De Vol E
Medicine (Baltimore); 2020 Oct; 99(43):e22621. PubMed ID: 33120750
[TBL] [Abstract][Full Text] [Related]
15. Cut-off values for sufficient cortisol response to low dose Short Synacthen Test after surgery for non-functioning pituitary adenoma.
Kolnes AJ; Øystese KA; Dahlberg D; Berg-Johnsen J; Niehusmann P; Pahnke J; Bollerslev J; Jørgensen AP
Acta Neurochir (Wien); 2020 Apr; 162(4):845-852. PubMed ID: 31907611
[TBL] [Abstract][Full Text] [Related]
16. Can a random serum cortisol reduce the need for short synacthen tests in acute medical admissions?
Kadiyala R; Kamath C; Baglioni P; Geen J; Okosieme OE
Ann Clin Biochem; 2010 Jul; 47(Pt 4):378-80. PubMed ID: 20488874
[TBL] [Abstract][Full Text] [Related]
17. Is a 0900-h serum cortisol useful prior to a short synacthen test in outpatient assessment?
Le Roux CW; Meeran K; Alaghband-Zadeh J
Ann Clin Biochem; 2002 Mar; 39(Pt 2):148-50. PubMed ID: 11930947
[TBL] [Abstract][Full Text] [Related]
18. The short Synacthen and insulin stress tests in the assessment of the hypothalamic-pituitary-adrenal axis.
Hurel SJ; Thompson CJ; Watson MJ; Harris MM; Baylis PH; Kendall-Taylor P
Clin Endocrinol (Oxf); 1996 Feb; 44(2):141-6. PubMed ID: 8849566
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease.
Abdu TA; Elhadd TA; Neary R; Clayton RN
J Clin Endocrinol Metab; 1999 Mar; 84(3):838-43. PubMed ID: 10084558
[TBL] [Abstract][Full Text] [Related]
20. Normal cortisol response to high-dose synacthen and insulin tolerance test in children and adults with Prader-Willi syndrome.
Farholt S; Sode-Carlsen R; Christiansen JS; Østergaard JR; Høybye C
J Clin Endocrinol Metab; 2011 Jan; 96(1):E173-80. PubMed ID: 20980432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]